The Marchesini Group has signed a 48% acquisition of SEA Vision, provider of vision and inspection systems used in quality control and drug anti-counterfeiting. The operation consolidates years of business between the two companies, worth 125 million Euro with a long-term strategic agreement.
SEA Vision, based in the Lombardy region, employs over 100 people and plans to hire more, as it expects solid growth in 2018 due to drug serialization requirements in the EU, USA and China and now also in Brazil, Russia and North Africa.
SEA Vision will remain technically and commercially independent and will still be managed by its founders—Luigi Carrioli and Michele Cei— assisted by the Sales Director Marco Baietti and the CFO Matteo Boiardi, backed in the Board of Directors by Maurizio Marchesini (President of the Marchesini Group), Pietro Cassani (CEO) and Pietro Tomasi (Sales Director).
“We have been faced with Industry 4.0 for almost 20 years, well before it became a real trend,” said Pietro Cassani. “This agreement will allow us to create packaging machines that are even more unified with SEA Vision’s systems in order to guarantee customers a true 4.0 asset.”
Maurizio Marchesini noted, “I have always thought, even when I was the Chairman of the Industrialists Association of Emilia Romagna, that the best way to define industry 4.0 is ‘digitalized manufacturing.”
At the headquarters in Pianoro, the Marchesini Group is set to inaugurate a new factory built entirely for 3D printing. As part of the concentration on Industry 4.0, the building will host all the 3D printers currently used by the Group, together with new models that will work 24 hours a day to prototype samples rapidly and to develop machine parts that up to now have been produced externally. The department will become the foundation of 4.0 at Marchesini, making it possible to curb costs and to monitor production planning, machine wear and tear and error management, all without even using a sheet of paper.
These actions will prompt a dynamic two-year period for the Marchesini Group. Building work will soon commence on the new cosmetic division. This business unit will support the pharmaceutical department focused on the rapidly-growing cosmetics packaging market both in Italy and abroad.
Another of the Group’s factories in Pianoro is being renovated and will be running shortly as a center of “Made in Italy excellence” thanks to Rinova, a new brand that will allow the Group to consolidate its business related to “second life” machinery.
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
